Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension: effects of endothelin receptor blockade.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 16093917)

Published in J Hypertens on September 01, 2005

Authors

James P Spiers1, Elizabeth J Kelso, Wei F Siah, Gillian Edge, Guojie Song, Barbara J McDermott, Martina Hennessy

Author Affiliations

1: Department of Pharmacology and Therapeutics, Trinity Centre for Health Sciences, Trinity College Dublin, St. James's Hospital, James's Street, Dublin 8, Ireland. spiersj@tcd.ie

Articles citing this

Redox signaling, vascular function, and hypertension. Antioxid Redox Signal (2008) 1.52

Vehicular emissions induce vascular MMP-9 expression and activity associated with endothelin-1-mediated pathways. Arterioscler Thromb Vasc Biol (2009) 1.38

Enhanced matrix metalloproteinase activity in the spontaneously hypertensive rat: VEGFR-2 cleavage, endothelial apoptosis, and capillary rarefaction. J Vasc Res (2010) 1.14

Chronic matrix metalloproteinase inhibition retards age-associated arterial proinflammation and increase in blood pressure. Hypertension (2012) 0.99

Endothelial endothelin B receptor-mediated prevention of cerebrovascular remodeling is attenuated in diabetes because of up-regulation of smooth muscle endothelin receptors. J Pharmacol Exp Ther (2010) 0.94

The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases. Br J Pharmacol (2012) 0.91

Increased plasma and tissue MMP levels are associated with BCSFB and BBB disruption evident on post-contrast FLAIR after experimental stroke. J Cereb Blood Flow Metab (2010) 0.88

An emerging role of degrading proteinases in hypertension and the metabolic syndrome: autodigestion and receptor cleavage. Curr Hypertens Rep (2012) 0.81

Age-associated pro-inflammatory remodeling and functional phenotype in the heart and large arteries. J Mol Cell Cardiol (2015) 0.81

Vascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical Implications. Can J Cardiol (2016) 0.80

Preexisting high expression of matrix metalloproteinase-2 in tunica media of saphenous vein conduits is associated with unfavorable long-term outcomes after coronary artery bypass grafting. Biomed Res Int (2013) 0.77

The role of reactive oxygen species in microvascular remodeling. Int J Mol Sci (2014) 0.76

THE AUTODIGESTION HYPOTHESIS AND RECEPTOR CLEAVAGE IN DIABETES AND HYPERTENSION. Drug Discov Today Dis Models (2011) 0.76

Articles by these authors

Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity. Circ Res (2008) 1.40

Small heat-shock protein Hsp20 attenuates beta-agonist-mediated cardiac remodeling through apoptosis signal-regulating kinase 1. Circ Res (2006) 1.35

Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy. Cancer Res (2010) 1.35

Nuclear receptor-mediated induction of CYP450 by antiretrovirals: functional consequences of NR1I2 (PXR) polymorphisms and differential prevalence in whites and sub-Saharan Africans. J Acquir Immune Defic Syndr (2010) 1.04

A human polymorphism of protein phosphatase-1 inhibitor-1 is associated with attenuated contractile response of cardiomyocytes to beta-adrenergic stimulation. FASEB J (2008) 0.90

Differential expression of components of the cardiomyocyte adrenomedullin/intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension. J Pharmacol Exp Ther (2005) 0.89

Inward rectifier potassium channels in the HL-1 cardiomyocyte-derived cell line. J Cell Physiol (2010) 0.87

Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix. Basic Res Cardiol (2015) 0.85

Expression of the counter-regulatory peptide intermedin is augmented in the presence of oxidative stress in hypertrophied cardiomyocytes. Cell Physiol Biochem (2008) 0.84

Temporal characteristics of cardiomyocyte hypertrophy in the spontaneously hypertensive rat. Cardiovasc Pathol (2004) 0.83

Protection of cardiomyocyte function by propofol during simulated ischemia is associated with a direct action to reduce pro-oxidant activity. J Mol Cell Cardiol (2007) 0.83

Effects of rosiglitazone and interactions with growth-regulating factors in ventricular cell hypertrophy. Eur J Pharmacol (2005) 0.82

Differential effects of an anti-oxidant intervention on cardiomyocyte expression of adrenomedullin and intermedin and their receptor components in chronic nitric oxide deficiency. Cell Physiol Biochem (2007) 0.81

SRIF receptor subtype expression and involvement in positive and negative contractile effects of somatostatin-14 (SRIF-14) in ventricular cardiomyocytes. Cell Physiol Biochem (2008) 0.79

Near-peer bedside clinical teaching: example of a successful programme. Clin Teach (2014) 0.78

Induction of hypertrophic responsiveness of cardiomyocytes to neuropeptide Y in response to pressure overload. J Pharmacol Exp Ther (2002) 0.78

Adrenomedullin gene delivery is cardio-protective in a model of chronic nitric oxide deficiency combining pressure overload, oxidative stress and cardiomyocyte hypertrophy. Cell Physiol Biochem (2010) 0.78

Neuropeptide Y Y(1) receptor regulates protein turnover and constitutive gene expression in hypertrophying cardiomyocytes. Eur J Pharmacol (2002) 0.77

Influence of atenolol and nifedipine on nitric-oxide deficient cardiomyocyte hypertrophy and expression of the cardio-endocrine peptide intermedin and its receptor components. Cell Physiol Biochem (2008) 0.77

Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide. Clin Ther (2011) 0.77

Evidence for altered ETB receptor characteristics during development and progression of ventricular cardiomyocyte hypertrophy. Am J Physiol Heart Circ Physiol (2004) 0.77

Modulation of contractile function through neuropeptide Y receptors during development of cardiomyocyte hypertrophy. J Pharmacol Exp Ther (2006) 0.76

Ribavirin and interferon alter MMP-9 abundance in vitro and in HIV-HCV-coinfected patients. Antivir Ther (2011) 0.76

Upregulation of adrenomedullin and its receptor components during cardiomyocyte hypertrophy induced by chronic inhibition of nitric oxide synthesis in rats. Am J Physiol Heart Circ Physiol (2005) 0.76

Statin therapy for patients with chronic heart failure. Am J Cardiol (2006) 0.75

HIV-1 Tat clade-specific cytokine induction in monocytes/macrophages is not evidenced in total or Vγ9Vδ2 T lymphocytes. AIDS (2014) 0.75

Unmet needs persist in pediatric HIV programs: lessons from selected case studies in Uganda. AIDS (2017) 0.75

Pro forma: impact on communication skills? Clin Teach (2013) 0.75

Prevalence of renal artery stenosis in flash pulmonary oedema: determination using gadolinium-enhanced MRA. Eur J Intern Med (2010) 0.75

Death and dignity through fresh eyes. Clin Teach (2011) 0.75

Effects of an endothelin receptor antagonist on a model of hypertensive retinopathy. Ophthalmic Res (2009) 0.75